Provided by Tiger Trade Technology Pte. Ltd.

Profound Medical Corp.

5.61
+0.20003.70%
Post-market: 5.45-0.1600-2.85%16:41 EDT
Volume:237.85K
Turnover:1.29M
Market Cap:203.60M
PE:-3.98
High:5.62
Open:5.41
Low:5.24
Close:5.41
52wk High:8.95
52wk Low:3.76
Shares:36.29M
Float Shares:33.94M
Volume Ratio:0.35
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4081
EPS(LYR):-1.4081
ROE:-67.12%
ROA:-34.91%
PB:3.06
PE(LYR):-3.98

Loading ...

Profound Medical pullback after Q4 report ‘misguided,’ says Lake Street

TIPRANKS
·
Mar 09

Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

GlobeNewswire
·
Mar 09

Profound Medical Q4 EPS $(0.27) Misses $(0.26) Estimate, Sales $5.977M Miss $7.233M Estimate

Benzinga
·
Mar 06

Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 06

Profound Medical Corp expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
Mar 04

Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow

GlobeNewswire
·
Feb 13

Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease

GlobeNewswire
·
Feb 12

Profound Medical, Pro Familia completed 500th Sonalleve Procedure

TIPRANKS
·
Feb 05

PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health

GlobeNewswire
·
Feb 05

Profound Medical Announces Upcoming Investor Events

GlobeNewswire
·
Jan 28

Profound Medical announces Mount Sinai Hospital treated patient with TULSA-PRO

TIPRANKS
·
Jan 15

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

GlobeNewswire
·
Jan 15

Profound Medical surpasses 2025 TULSA-PRO installed base goal

TIPRANKS
·
Jan 12

Profound Surpasses 2025 TULSA-PRO® Installed Base Goal

GlobeNewswire
·
Jan 12

Profound Medical Is Maintained at Buy by Lake Street

Dow Jones
·
Jan 08

Profound Medical Says Johns Hopkins Treats First Patient With Tulsa-Pro Prostate Cancer Therapy

MT Newswires Live
·
Jan 07

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

GlobeNewswire
·
Jan 06

Profound Medical Corp. Announces Closing of Private Placement

GlobeNewswire
·
Dec 31, 2025

Profound Medical Corp Upsizes Private Placement to $6.45M to Fund Sales, R&D Expansion

MT Newswires Live
·
Dec 26, 2025

Profound Medical Corp. Announces Upsize of Private Placement

GlobeNewswire
·
Dec 25, 2025